Drug intelligence / Profile preview

MCP-311

Development stage: Preclinical
Lead developer: Synthonics
Modality: Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration: Oral

Overview

MCP-311 is a metal-coordinated polymer drug candidate being developed by Synthonics for the treatment of Parkinson's disease. It is a bismuth-levodopa co-polymer created using Synthonics' proprietary metal coordination technology, which links the small molecule drug (levodopa) with a metal ion (bismuth) to form a polymer. This formulation is designed to provide a controlled and sustained release of levodopa, aiming to maintain more consistent therapeutic levels in the blood and reduce the motor fluctuations and "off" periods associated with standard levodopa treatments. MCP-311 is currently in the preclinical stage of development and is considered the lead candidate for Parkinson's disease in the Synthonics pipeline.

Other names: bismuth-levodopa co-polymer

Targets

DRD (Dopamine receptors)

Beyond the preview

Go deeper on MCP-311.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MCP-311.

Explore the full profile